RSV Protection Before Baby: Maternal Vaccine or Infant Antibody?

September is when many expecting families start thinking about fall layers, hospital bags, and the final weeks before baby. It is also the beginning of an important RSV planning window.

Respiratory syncytial virus, or RSV, often causes cold-like illness, but it can be serious for young infants. The Centers for Disease Control and Prevention (CDC) says RSV season generally begins in the fall and peaks in winter in most parts of the United States.

Parents now have two ways to help protect a baby from severe RSV during the first season: a maternal vaccine during pregnancy or a long-acting antibody given to the infant. Most babies do not need both. Understanding the timing before delivery makes the conversation with your prenatal and pediatric care teams much easier.

The two RSV protection paths

Option 1: Maternal RSV vaccination during pregnancy

CDC recommends one dose of Pfizer’s Abrysvo for eligible pregnant patients from 32 weeks 0 days through 36 weeks 6 days of pregnancy. In most of the continental United States, it is given from September through January.

The pregnant parent’s immune system makes antibodies after vaccination and passes some of them to the baby before birth. Those antibodies are intended to help protect the newborn during the first RSV season.

There is an important name to remember: Abrysvo is the only RSV vaccine recommended for use during pregnancy. Other RSV vaccines used for older adults are not approved for pregnant patients. Ask your clinician to confirm the product and timing before it is administered.

If you are already past 36 weeks 6 days, CDC guidance says there may not be enough time for antibodies to develop and cross the placenta before birth. In that situation, the care team will generally discuss the infant-antibody path instead.

Option 2: A long-acting RSV antibody for baby

Nirsevimab and clesrovimab are long-acting monoclonal antibodies that can protect eligible infants from severe RSV disease. They are not vaccines: they provide ready-made antibodies rather than asking the baby’s immune system to produce them.

Under current CDC infant RSV guidance, an infant antibody is recommended for babies younger than 8 months who are born during or entering their first RSV season when:

• The mother did not receive the maternal RSV vaccine during pregnancy;
• The mother’s vaccination status is unknown; or
• The baby was born within 14 days after the maternal RSV vaccine was given.

For most babies born at least 14 days after maternal vaccination, an infant RSV antibody is not needed. Rare medical circumstances can change that decision, so the baby’s clinician should make the final recommendation.

Why September is the right time to make a plan

The two options use different calendars. The maternal vaccine window begins in September for most of the continental U.S. Infant RSV antibodies are generally administered from October through March.

Babies born from October 1 through March 31 who qualify for an infant antibody should ideally receive it within their first week of life, often during the birth hospitalization. Eligible babies born from April through September are generally immunized shortly before the season begins, often in October or November.

Timing can differ in Alaska, tropical climates, and communities where RSV activity is less predictable. Local health departments and healthcare systems may adjust their schedules based on regional RSV circulation.

A simple RSV planning checklist

1. Check your gestational week. Write down when you will enter and leave the 32-through-36-week maternal vaccination window.
2. Compare that window with the calendar. In most of the continental U.S., maternal RSV vaccination is offered September through January.
3. Ask about product availability. Confirm whether your prenatal practice, pharmacy, hospital, or pediatric office carries the recommended option.
4. Choose the baby’s clinician before delivery. The pediatric team may need the maternal vaccine date to determine whether an infant antibody is recommended.
5. Record the details. Save the vaccine name, administration date, and gestational week in your phone and birth-plan notes.
6. Share the plan at admission. Tell the delivery team whether maternal RSV vaccination occurred and on what date.
7. Confirm the outcome. Before discharge, ask whether your baby needs an RSV antibody and where it will be documented.

Questions to bring to your next appointment

• Will I be between 32 weeks 0 days and 36 weeks 6 days during the recommended seasonal window?
• Do you recommend maternal Abrysvo or an infant antibody for our baby’s expected birth month?
• If I choose maternal vaccination, where can I receive it and how should I document it?
• If baby arrives within 14 days of the vaccine, how will the plan change?
• Does our location follow the standard September–January and October–March timing?
• Will the birth hospital stock nirsevimab or clesrovimab if baby is eligible?
• Are there medical factors that make one option more appropriate for us?

Three common points of confusion

“The infant antibody is just another vaccine.”

It is not. Nirsevimab and clesrovimab supply antibodies directly. They do not activate the baby’s immune system in the same way a vaccine does.

“Every baby should receive both forms of protection.”

Most infants will not need both maternal vaccination and an infant antibody. The maternal vaccine date, the baby’s birth date, and certain medical circumstances guide the decision.

“The timing is identical everywhere.”

The standard windows apply to most of the continental U.S., but RSV circulation varies geographically. Families in Alaska, southern Florida, Hawaii, Puerto Rico, U.S. territories, and other tropical locations should ask about local timing.

Add the plan to your baby-preparation notes

RSV protection is easier to coordinate when it is written down. Add the selected path and any appointment date to your baby-preparation checklist. Place a copy of the maternal vaccine record with the documents in your hospital bag, and ask about the RSV plan when you review your baby’s newborn screening results.

For the complete recommendations, review the CDC’s current maternal RSV vaccine guidance and infant guidance with your healthcare team.

This article is for general education and does not diagnose, treat, or replace individualized medical advice. Recommendations, availability, insurance coverage, and local timing can change. Ask your obstetric, midwifery, pediatric, or family-care clinician which RSV protection plan is appropriate for you and your baby.